| scholarly article | Q13442814 |
| P50 | author | Lutgarde Buydens | Q27061944 |
| Lionel Blanchet | Q56256928 | ||
| Agnieszka Smolinska | Q36629891 | ||
| P2093 | author name string | Sybren S Wijmenga | |
| P2860 | cites work | Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions | Q27860828 |
| Statistical strategies for avoiding false discoveries in metabolomics and related experiments | Q27887473 | ||
| Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 | ||
| CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis | Q28287666 | ||
| 1H NMR characterization of normal human cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B12 deficient patient | Q28333724 | ||
| High resolution 1H n.m.r. studies of vertebrate blood and plasma | Q28366574 | ||
| Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects | Q28367027 | ||
| Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid | Q28469239 | ||
| Metabolomics – the link between genotypes and phenotypes | Q28540942 | ||
| Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis | Q28728670 | ||
| Unfolding the long-term pathophysiological processes following an acute inflammatory demyelinating lesion of multiple sclerosis | Q43195425 | ||
| Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification | Q43271462 | ||
| Detection of urinary drug metabolite (xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy. | Q43755752 | ||
| The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy | Q43992446 | ||
| NMR-based characterization of metabolic alterations in hypertension using an adaptive, intelligent binning algorithm | Q44277684 | ||
| Classification and differential metabolite discovery of liver diseases based on plasma metabolic profiling and support vector machines | Q44451691 | ||
| A Backward Variable Selection method for PLS regression (BVSPLS). | Q44770180 | ||
| Possibilities of selective screening for inborn errors of metabolism using high-resolution 1H-FT-NMR spectrometry | Q44838391 | ||
| Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis | Q45005560 | ||
| Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics | Q45119909 | ||
| Evaluation of full-resolution J-resolved 1H NMR projections of biofluids for metabonomics information retrieval and biomarker identification | Q45162117 | ||
| Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. | Q45207757 | ||
| Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. | Q45222765 | ||
| A metabolomic approach to lung cancer | Q45297639 | ||
| (1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease. | Q45304040 | ||
| Stability-based biomarker selection. | Q45901332 | ||
| A microfluidic high-resolution NMR flow probe. | Q46075312 | ||
| Dynamic biochemical information recovery in spontaneous human seminal fluid reactions via 1H NMR kinetic statistical total correlation spectroscopy | Q46178669 | ||
| NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse. | Q46461411 | ||
| Metabolite profiling of human amniotic fluid by hyphenated nuclear magnetic resonance spectroscopy | Q46531350 | ||
| Metabolomic profiling to develop blood biomarkers for Parkinson's disease | Q46789088 | ||
| High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria. | Q46849835 | ||
| Heteronuclear 1H-31P statistical total correlation NMR spectroscopy of intact liver for metabolic biomarker assignment: application to galactosamine-induced hepatotoxicity | Q46921681 | ||
| Potential of NMR spectroscopy for the study of human amniotic fluid | Q46964387 | ||
| A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease | Q47401613 | ||
| Systems biology: Metabonomics | Q47647280 | ||
| Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions | Q48182289 | ||
| Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. | Q48351781 | ||
| Recursive segment-wise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery. | Q48460973 | ||
| A possible new diagnostic biomarker in early diagnosis of Alzheimer's disease. | Q48461732 | ||
| Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study. | Q48752891 | ||
| High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques. | Q48844459 | ||
| Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra. | Q51598103 | ||
| Processing and modeling of nuclear magnetic resonance (NMR) metabolic profiles. | Q51617326 | ||
| Alignment of high resolution magic angle spinning magnetic resonance spectra using warping methods. | Q51635006 | ||
| Robust baseline correction algorithm for signal dense NMR spectra. | Q51912796 | ||
| Probing latent biomarker signatures and in vivo pathway activity in experimental disease states via statistical total correlation spectroscopy (STOCSY) of biofluids: application to HgCl2 toxicity. | Q51940601 | ||
| Peak alignment of urine NMR spectra using fuzzy warping. | Q51945191 | ||
| Factors affecting the robustness of metabolite fingerprinting using 1H NMR spectra. | Q52022397 | ||
| Toward single-calibrant quantification in HPLC. A comparison of three detection strategies: evaporative light scattering, chemiluminescent nitrogen, and proton NMR. | Q52979708 | ||
| The mechanism of galactosamine toxicity revisited; a metabonomic study. | Q53545394 | ||
| The differential diagnosis of multiple sclerosis. | Q55043560 | ||
| A genetic algorithm tutorial | Q55951460 | ||
| Two‐dimensional spectroscopy. Application to nuclear magnetic resonance | Q56060737 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| PLS-regression: a basic tool of chemometrics | Q56454404 | ||
| The Impact of Delayed Storage on the Measured Proteome and Metabolome of Human Cerebrospinal Fluid | Q56982090 | ||
| Functional prediction of unidentified lipids using supervised classifiers | Q57012199 | ||
| The human cerebrospinal fluid metabolome | Q57014395 | ||
| Proteomics and the Human Metabolome Project | Q57014410 | ||
| A branched-chain organic acid linked to multiple sclerosis: first identification by NMR spectroscopy of CSF | Q57274236 | ||
| A tutorial on spectral clustering | Q57408123 | ||
| Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy | Q57803393 | ||
| Validation of a urine metabolome fingerprint in dog for phenotypic classification | Q57803458 | ||
| Metabolic Biomarkers of Prenatal Disorders: An Exploratory NMR Metabonomics Study of Second Trimester Maternal Urine and Blood Plasma | Q58040349 | ||
| Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma | Q58040357 | ||
| Intra- and inter-omic fusion of metabolic profiling data in a systems biology framework | Q58045659 | ||
| Analytical technologies for metabonomics and metabolomics, and multi-omic information recovery | Q58045746 | ||
| Statistical Correlation and Projection Methods for Improved Information Recovery from Diffusion-Edited NMR Spectra of Biological Samples | Q58045879 | ||
| Assessment of Analytical Reproducibility of1H NMR Spectroscopy Based Metabonomics for Large-Scale Epidemiological Research: the INTERMAP Study | Q58045895 | ||
| Chemometric Models for Toxicity Classification Based on NMR Spectra of Biofluids | Q58046186 | ||
| Nuclear Magnetic Resonance Spectroscopic and Principal Components Analysis Investigations into Biochemical Effects of Three Model Hepatotoxins | Q58046285 | ||
| Proton NMR analysis of plasma from renal failure patients: Evaluation of sample preparation and spectral-editing methods | Q58046500 | ||
| High resolution proton magnetic resonance spectroscopy of biological fluids | Q58046528 | ||
| Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS | Q58125385 | ||
| Improved parametric time warping for proteomics | Q58342382 | ||
| Individual Human Phenotypes in Metabolic Space and Time | Q58619089 | ||
| Variable selection in regression-a tutorial | Q59430756 | ||
| A modification of canonical variates analysis to handle highly collinear multivariate data | Q59430920 | ||
| Self Organising Maps for variable selection: Application to human saliva analysed by nuclear magnetic resonance spectroscopy to investigate the effect of an oral healthcare product | Q61824621 | ||
| Elimination of Uninformative Variables for Multivariate Calibration | Q62924505 | ||
| NMR at earth’s magnetic field using para-hydrogen induced polarization | Q63536708 | ||
| 1H NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine | Q63965460 | ||
| Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis | Q73107443 | ||
| 1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like disease | Q73535524 | ||
| NMR of biofluids and pattern recognition: assessing the impact of NMR parameters on the principal component analysis of urine from rat and mouse | Q74320136 | ||
| Further assignment of resonances in 1H NMR spectra of cerebrospinal fluid (CSF) | Q74480903 | ||
| A Perfect Smoother | Q79189954 | ||
| Metabolomics applied to exhaled breath condensate in childhood asthma | Q79782755 | ||
| Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics | Q79813217 | ||
| Uniform procedure of (1)H NMR analysis of rat urine and toxicometabonomics Part II: comparison of NMR profiles for classification of hepatotoxicity | Q80125490 | ||
| Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles | Q80803763 | ||
| Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy | Q81228751 | ||
| Salivary metabolite signatures of oral cancer and leukoplakia | Q83053879 | ||
| Study of acute biochemical effects of thallium toxicity in mouse urine by NMR spectroscopy | Q83157215 | ||
| Tuberculous meningitis with positive cell-count in lumbar puncture CSF though negative cell-count from ventricular drainage CSF | Q83582138 | ||
| Concentration Measurement by Proton NMR Using the ERETIC Method | Q84332014 | ||
| NMR and pattern recognition can distinguish neuroinflammation and peripheral inflammation | Q84631913 | ||
| NMR quantification using an artificial signal | Q84965885 | ||
| Quantification of 1H NMR spectra of human cerebrospinal fluid: a protocol based on constrained total-line-shape analysis | Q109320667 | ||
| Water Suppression That Works. Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients | Q110653061 | ||
| An introduction to multisensor data fusion | Q114864602 | ||
| Homonuclear broad band decoupling and two‐dimensional J‐resolved NMR spectroscopy | Q114867333 | ||
| How the 1D-NOESY suppresses solvent signal in metabonomics NMR spectroscopy: An examination of the pulse sequence components and evolution | Q114867708 | ||
| Assessment of PLSDA cross validation | Q114867960 | ||
| Consequences of sample size, variable selection, and model validation and optimisation, for predicting classification ability from analytical data | Q114868272 | ||
| PLS regression methods | Q114871458 | ||
| 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data | Q29784220 | ||
| Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets | Q30983576 | ||
| Fusion of mass spectrometry-based metabolomics data | Q31011308 | ||
| Scaling and normalization effects in NMR spectroscopic metabonomic data sets | Q31035575 | ||
| Targeted profiling: quantitative analysis of 1H NMR metabolomics data | Q31047473 | ||
| Interpretation of ANOVA models for microarray data using PCA. | Q31077024 | ||
| Differential diagnosis of multiple sclerosis | Q31113892 | ||
| Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. | Q31800788 | ||
| Cluster analysis statistical spectroscopy using nuclear magnetic resonance generated metabolic data sets from perturbed biological systems | Q33485423 | ||
| The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF). | Q33511637 | ||
| A transcriptomic computational analysis of mastic oil-treated Lewis lung carcinomas reveals molecular mechanisms targeting tumor cell growth and survival | Q33518037 | ||
| Visualization and recovery of the (bio)chemical interesting variables in data analysis with support vector machine classification | Q33655480 | ||
| Bile acids conjugation in human bile is not random: new insights from (1)H-NMR spectroscopy at 800 MHz | Q33764381 | ||
| A new strategy of exploring metabolomics data using Monte Carlo tree. | Q33771775 | ||
| Nuclear magnetic resonance (NMR)-based metabolomics | Q33785980 | ||
| Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer | Q33794134 | ||
| Statistical integration of 1H NMR and MRS data from different biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection | Q33796091 | ||
| Multivariate data analysis in pharmaceutics: a tutorial review | Q33824713 | ||
| Transcriptomic analysis of Clostridium thermocellum ATCC 27405 cellulose fermentation | Q33932231 | ||
| Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis | Q33940116 | ||
| Descriptive review of current NMR-based metabolomic data analysis packages | Q34020183 | ||
| Non-linear modeling of 1H NMR metabonomic data using kernel-based orthogonal projections to latent structures optimized by simulated annealing | Q34036454 | ||
| An integrated workflow for robust alignment and simplified quantitative analysis of NMR spectrometry data | Q34052563 | ||
| Systematic functional analysis of the yeast genome | Q34067467 | ||
| Pattern recognition analysis of high resolution 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data | Q34070223 | ||
| Metabolic profiling and the metabolome-wide association study: significance level for biomarker identification | Q34135639 | ||
| Metabonomics: a platform for studying drug toxicity and gene function | Q34139125 | ||
| Vertigo and multiple sclerosis: aspects of differential diagnosis. | Q34496268 | ||
| Differential diagnosis in multiple sclerosis. | Q34496284 | ||
| The role of analytical sciences in medical systems biology | Q34551383 | ||
| Metabolic fingerprinting as a diagnostic tool. | Q34699756 | ||
| Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts | Q34714204 | ||
| Reversible interactions with para-hydrogen enhance NMR sensitivity by polarization transfer. | Q34969900 | ||
| Prediction of metabolic reactions based on atomic and molecular properties of small-molecule compounds. | Q35007800 | ||
| Biological networks | Q35119735 | ||
| The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses | Q35527861 | ||
| Quantitative 1H NMR: development and potential of a method for natural products analysis. | Q36023495 | ||
| The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? | Q36428339 | ||
| 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death | Q36496258 | ||
| The application of NMR-based metabonomics in neurological disorders | Q36525175 | ||
| Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders | Q36630012 | ||
| Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classification of samples | Q36714245 | ||
| Automatic data reduction and pattern recognition methods for analysis of 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. | Q36728660 | ||
| NMR-based metabolomics approach to target biomarkers for human prostate cancer | Q36841884 | ||
| Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes | Q36842641 | ||
| How to avoid over-fitting in multivariate calibration--the conventional validation approach and an alternative. | Q36867604 | ||
| Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics | Q37004712 | ||
| NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology | Q37048627 | ||
| Metabolomics-based methods for early disease diagnostics | Q37266489 | ||
| Metabolomics tools for identifying biomarkers for neuropsychiatric diseases | Q37419784 | ||
| Cerebrospinal fluid biomarkers in multiple sclerosis | Q37475259 | ||
| Analytical and statistical approaches to metabolomics research | Q37537294 | ||
| Metabonomics: a useful tool for the future surgeon | Q37547435 | ||
| From biomarker strategies to biomarker activities and back | Q37636775 | ||
| Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy | Q37780690 | ||
| Accuracy of diagnostic tests in multiple sclerosis--a systematic review | Q37808715 | ||
| Metabolic profiling in multiple sclerosis and other disorders by quantitative analysis of cerebrospinal fluid using nuclear magnetic resonance spectroscopy | Q37861812 | ||
| A decade in prostate cancer: from NMR to metabolomics | Q37876681 | ||
| Metabolomics and bladder cancer | Q37935192 | ||
| Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook | Q37943853 | ||
| Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS. | Q39446765 | ||
| Effect of pH changes in cerebrospinal fluid specimens on bacterial survival and antigen test results | Q39584590 | ||
| A decade of advances in metabonomics | Q39795394 | ||
| NMR metabolic analysis of samples using fuzzy K-means clustering | Q39803560 | ||
| Pattern recognition approaches in biomedical and clinical magnetic resonance spectroscopy: a review. | Q41668595 | ||
| Visualization of bile homeostasis using (1)H-NMR spectroscopy as a route for assessing liver cancer | Q41935417 | ||
| Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion | Q41981553 | ||
| 600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances | Q42286903 | ||
| icoshift: A versatile tool for the rapid alignment of 1D NMR spectra | Q42642473 | ||
| Evaluation of standard and advanced preprocessing methods for the univariate analysis of blood serum 1H-NMR spectra. | Q42935527 | ||
| Interdependence of signal processing and analysis of urine 1H NMR spectra for metabolic profiling | Q42960221 | ||
| Metabolic classification of South American Ilex species by NMR-based metabolomics | Q43143943 | ||
| P921 | main subject | pattern recognition | Q378859 |
| biomarker | Q864574 | ||
| data acquisition | Q1172399 | ||
| metabolomics | Q12149006 | ||
| P304 | page(s) | 82-97 | |
| P577 | publication date | 2012-06-09 | |
| P1433 | published in | Analytica Chimica Acta | Q1767639 |
| P1476 | title | NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review | |
| P478 | volume | 750 |
| Q36539963 | 'Omics' approaches to understanding interstitial cystitis/painful bladder syndrome/bladder pain syndrome |
| Q40133625 | (1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis |
| Q52686989 | 1H NMR metabolic signature of cerebrospinal fluid following repetitive lower-limb remote ischemia preconditioning. |
| Q91642772 | 1H NMR metabolomic analysis of skin and blubber of bottlenose dolphins reveals a functional metabolic dichotomy |
| Q91081536 | 1H NMR-Based Metabolomics Reveals the Antitumor Mechanisms of Triptolide in BALB/c Mice Bearing CT26 Tumors |
| Q30991262 | A correction method for systematic error in (1)H-NMR time-course data validated through stochastic cell culture simulation |
| Q63214074 | A dynamic probabilistic principal components model for the analysis of longitudinal metabolomics data |
| Q51738959 | A resonance light scattering sensor based on bioinspired molecularly imprinted polymers for selective detection of papain at trace levels. |
| Q114145672 | A survey of deep nonnegative matrix factorization |
| Q38499220 | A tutorial review: Metabolomics and partial least squares-discriminant analysis--a marriage of convenience or a shotgun wedding |
| Q30857236 | Advancements in waste water characterization through NMR spectroscopy: review |
| Q38607534 | Advances in metabolome information retrieval: turning chemistry into biology. Part II: biological information recovery |
| Q91304536 | An NMR based panorama of the heterogeneous biology of acute respiratory distress syndrome (ARDS) from the standpoint of metabolic biomarkers |
| Q35534684 | An UPLC-MS-based metabolomics investigation on the anti-fatigue effect of salidroside in mice |
| Q31126816 | An approach to the simultaneous quantitative analysis of metabolites in table wines by (1)H NMR self-constructed three-dimensional spectra. |
| Q30606360 | An efficient spectra processing method for metabolite identification from 1H-NMR metabolomics data |
| Q39181729 | Analysis of short-chain fatty acids in human feces: A scoping review |
| Q100481031 | Analytical Metabolomics and Applications in Health, Environmental and Food Science |
| Q49464422 | Application of Metabolomics in Alzheimer's Disease. |
| Q59793709 | Application of metabolomics in toxicity evaluation of traditional Chinese medicines |
| Q36849513 | Applications of NMR spectroscopy to systems biochemistry |
| Q92169368 | Baicalein attenuates the neuroinflammation in LPS-activated BV-2 microglial cells through suppression of pro-inflammatory cytokines, COX2/NF-κB expressions and regulation of metabolic abnormality |
| Q38581263 | Bioinformatics tools for the analysis of NMR metabolomics studies focused on the identification of clinically relevant biomarkers |
| Q38133894 | Biomarkers in pharmacology and drug discovery |
| Q26772073 | Blood transcriptomics and metabolomics for personalized medicine |
| Q39400057 | Boosting model performance and interpretation by entangling preprocessing selection and variable selection. |
| Q36249269 | Brain metabolic pattern analysis using a magnetic resonance spectra classification software in experimental stroke |
| Q63849397 | Breaking with trends in pre-processing? |
| Q99634917 | Bridging Targeted and Untargeted Mass Spectrometry-Based Metabolomics via Hybrid Approaches |
| Q92052827 | Cancer metabolomic markers in urine: evidence, techniques and recommendations |
| Q95841072 | Cannabinomics: Application of Metabolomics in Cannabis (Cannabis sativa L.) Research and Development |
| Q104496751 | Cerebrospinal fluid metabolites in tryptophan-kynurenine and nitric oxide pathways: biomarkers for acute neuroinflammation |
| Q47774158 | Chaihu-Shu-Gan-San regulates phospholipids and bile acid metabolism against hepatic injury induced by chronic unpredictable stress in rat. |
| Q93036111 | Chemical Barcoding: A Nuclear-Magnetic-Resonance-Based Approach To Ensure the Quality and Safety of Natural Ingredients |
| Q37561520 | Children with severe asthma have unique oxidative stress-associated metabolomic profiles |
| Q93055763 | Chronic kidney disease: Biomarker diagnosis to therapeutic targets |
| Q38575535 | Comparative Proteomics for the Evaluation of Protein Expression and Modifications in Neurodegenerative Diseases |
| Q120405845 | Comparative analysis of methods and model prediction performance evaluation for continuous online non-invasive quality assessment during drying of apples from two cultivars |
| Q31081933 | Comparative effects of dexamethasone and bergenin on chronic bronchitis and their anti-inflammatory mechanisms based on NMR metabolomics |
| Q114870848 | Comparison of Microflow and Analytical Flow Liquid Chromatography Coupled to Mass Spectrometry Global Metabolomics Methods Using a Urea Cycle Disorder Mouse Model |
| Q114870400 | Computational and statistical analysis of metabolomics data |
| Q38834652 | Computer-Aided 13C NMR Chemical Profiling of Crude Natural Extracts without Fractionation |
| Q98881748 | Connecting the dots: Advances in modern metabolomics and its application in yeast system |
| Q114866859 | Current Challenges and Recent Developments in Mass Spectrometry–Based Metabolomics |
| Q35685689 | Current status and prospects of computational resources for natural product dereplication: a review |
| Q35828038 | Data Fusion in Metabolomics and Proteomics for Biomarker Discovery |
| Q37294147 | Deciphering the Duality of Clock and Growth Metabolism in a Cell Autonomous System Using NMR Profiling of the Secretome. |
| Q100996295 | Determination of the Geographical Origin of Asparagus officinalis L. by 1H NMR Spectroscopy |
| Q58605526 | Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS) |
| Q33670799 | Diagnostic Applications of Nuclear Magnetic Resonance-Based Urinary Metabolomics |
| Q87615919 | Direct nuclear magnetic resonance identification and quantification of geometric isomers of conjugated linoleic acid in milk lipid fraction without derivatization steps: overcoming sensitivity and resolution barriers |
| Q38827748 | Dynamic collection and analysis of volatile organic compounds from the headspace of cell cultures |
| Q47693439 | Dynamic nuclear polarization facilitates monitoring of pyruvate metabolism in Trypanosoma brucei |
| Q35937965 | Effect of Cosmos caudatus (Ulam raja) supplementation in patients with type 2 diabetes: Study protocol for a randomized controlled trial. |
| Q37207769 | Emerging applications of metabolomics in studying chemopreventive phytochemicals. |
| Q88561763 | Empowering thyroid hormone research in human subjects using OMICs technologies |
| Q30890929 | Enhancing metabolomics research through data mining |
| Q38389338 | Extracting biomarkers of commitment to cancer development: potential role of vibrational spectroscopy in systems biology |
| Q42634000 | Focus: a robust workflow for one-dimensional NMR spectral analysis |
| Q41344548 | Fragment-based de novo design of a cystathionine γ-lyase selective inhibitor blocking hydrogen sulfide production |
| Q114865978 | From sample preparation to NMR‐based metabolic profiling in food commodities: The case of table olives |
| Q46514880 | GC-MS based metabolomics of colon cancer cells using different extraction solvents. |
| Q91670546 | Genetic variance of metabolomic features and their relationship with body weight and body weight gain in Holstein cattle1 |
| Q30832979 | Getting your peaks in line: a review of alignment methods for NMR spectral data |
| Q26738283 | Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health |
| Q40158243 | Has your ancient stamp been regummed with synthetic glue? A FT-NIR and FT-Raman study |
| Q48167364 | High Aerobic Capacity Mitigates Changes in the Plasma Metabolomic Profile Associated with Aging. |
| Q57531651 | High-Resolution 1H-NMR Spectroscopy and Beyond to Explore Plant Metabolome |
| Q57176244 | High-throughput metabolomics by 1D NMR |
| Q59780868 | Hochdurchsatz-Metabolomik mit 1D-NMR |
| Q28079419 | Holistic Analysis Enhances the Description of Metabolic Complexity in Dietary Natural Products |
| Q36998261 | Identification and MS-assisted interpretation of genetically influenced NMR signals in human plasma |
| Q37682966 | Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis |
| Q57998393 | Impact of maternal obesity on the metabolic profiles of pregnant women and their offspring at birth |
| Q59804183 | Impact of meropenem on Klebsiella pneumoniae metabolism |
| Q89059686 | Improving metabolome coverage and data quality: advancing metabolomics and lipidomics for biomarker discovery |
| Q46828031 | In vivo NMR spectroscopy: toward real time monitoring of environmental stress |
| Q37512752 | Influence of Freezing and Storage Procedure on Human Urine Samples in NMR-Based Metabolomics |
| Q94334835 | Influence of Metabolite Extraction Methods on H-NMR-Based Metabolomic Profiling of Enteropathogenic |
| Q43903361 | Infrared biospectroscopy for a fast qualitative evaluation of sample preparation in metabolomics |
| Q47206010 | Instrumental drift removal in GC-MS data for breath analysis: the short-term and long-term temporal validation of putative biomarkers for COPD. |
| Q114864564 | Interpretation of type 2 diabetes mellitus relevant GC-MS metabolomics fingerprints by using random forests |
| Q92600162 | Library-assisted nonlinear blind separation and annotation of pure components from a single 1H nuclear magnetic resonance mixture spectra |
| Q38554197 | Lipid and Metabolic Changes in Rheumatoid Arthritis. |
| Q30855632 | Lipid characterization of individual porcine oocytes by dual mode DESI-MS and data fusion. |
| Q30984358 | Lipidomic data analysis: tutorial, practical guidelines and applications |
| Q38764689 | Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective |
| Q28829367 | Magic angle spinning NMR spectroscopy: a versatile technique for structural and dynamic analysis of solid-phase systems |
| Q45899917 | Magnetic susceptibility to measure total protein concentration from NMR metabolite spectra: Demonstration on blood plasma. |
| Q45384812 | Medical perspectives of metabolomics: the example of renal carcinoma |
| Q35996192 | Metabolic Biomarker Panels of Response to Fusarium Head Blight Infection in Different Wheat Varieties |
| Q38894849 | Metabolic Phenotyping of Diet and Dietary Intake |
| Q89596390 | Metabolic fingerprinting of banana passion fruits and its correlation with quorum quenching activity |
| Q91375276 | Metabolite Profiling of Clinical Cancer Biofluid Samples by NMR Spectroscopy |
| Q55440293 | Metabolites Re-programming and Physiological Changes Induced in Scenedesmus regularis under Nitrate Treatment. |
| Q91477421 | Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia |
| Q39637114 | Metabolomic analysis of glycerophospholipid signatures of inflammation treated with non-steroidal anti-inflammatory drugs-induced-RAW264.7 cells using (1)H NMR and U-HPLC/Q-TOF-MS. |
| Q33751810 | Metabolomic and proteomic investigations of impacts of titanium dioxide nanoparticles on Escherichia coli |
| Q37685038 | Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosis. |
| Q47674922 | Metabolomic profile in hyperthyroid patients before and after antithyroid drug treatment: Correlation with thyroid hormone and TSH concentration. |
| Q40247929 | Metabolomic study of the fever model induced by baker's yeast and the antipyretic effects of aspirin in rats using nuclear magnetic resonance and gas chromatography-mass spectrometry |
| Q28068862 | Metabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis Research |
| Q118711047 | Metabolomics and Metabolic Profiling: Investigation of Dynamic Plant-Environment Interactions at the Functional Level |
| Q28084835 | Metabolomics and diabetes: analytical and computational approaches |
| Q27144251 | Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery |
| Q53054318 | Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine. |
| Q41663962 | Metabolomics as a promising tool for early osteoarthritis diagnosis |
| Q39376390 | Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine |
| Q58132053 | Metabolomics in Systems Biology |
| Q38262695 | Metabolomics in dyslipidemia. |
| Q27016117 | Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases |
| Q38108091 | Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy. |
| Q60193145 | Metabolomics in the Study of Alzheimer's Disease |
| Q26992344 | Metabolomics of human brain aging and age-related neurodegenerative diseases |
| Q85296360 | Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease |
| Q38705767 | Metabolomics: Perspectives on potential biomarkers in organ transplantation and immunosuppressant toxicity |
| Q57212257 | Metabonomic analysis of serum of workers occupationally exposed to arsenic, cadmium and lead for biomarker research: a preliminary study |
| Q39039710 | Metabonomics and drug development |
| Q38550492 | Metabonomics in the preclinical and environmental toxicity field |
| Q26747593 | Metagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome Analysis |
| Q113253234 | Modeling of Antioxidant Activity, Polyphenols and Macronutrients Content of Bee Pollen Applying Solid-State 13C NMR Spectra |
| Q114865291 | Multi-Omics Strategies for Investigating the Microbiome in Toxicology Research |
| Q46907074 | Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania |
| Q41942567 | Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors |
| Q49834349 | NMR Analysis of Fecal Samples. |
| Q60419193 | NMR Spectroscopy Metabolomics Applied to Crack Cocaine Users and Patients with Schizophrenia: Similar Behavior but Different Molecular Causes |
| Q93108710 | NMR Spectroscopy for Metabolomics Research |
| Q63965445 | NMR Studies of Inborn Errors of Metabolism |
| Q41127962 | NMR metabolomics highlights sphingosine kinase-1 as a new molecular switch in the orchestration of aberrant metabolic phenotype in cancer cells |
| Q60952351 | NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system |
| Q45353721 | NMR metabolomics profiling of blood plasma mimics shows that medium- and long-chain fatty acids differently release metabolites from human serum albumin |
| Q87009733 | NMR metabonomics of cerebrospinal fluid distinguishes between Parkinson's disease and controls |
| Q34446558 | NMR spectroscopy for metabolomics and metabolic profiling. |
| Q120433823 | NMR spectroscopy of wastewater: A review, case study, and future potential |
| Q57947485 | NMR-Based Metabolomics in Food Quality Control |
| Q92972564 | NMR-Based Metabolomics of Food |
| Q57016043 | NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations |
| Q38279711 | NMR-based metabolomics: from sample preparation to applications in nutrition research |
| Q46802419 | NMR-based metabonomics survey in rats envenomed by Hemiscorpius lepturus venom. |
| Q47691618 | NMR-based untargeted metabolomic study of hydrogen peroxide-induced development and diapause termination in brine shrimp |
| Q89546867 | NMR-based urine metabolic profiling and immunohistochemistry analysis of nephron changes in a mouse model of hypoxia-induced acute kidney injury |
| Q41332699 | Navigating freely-available software tools for metabolomics analysis |
| Q91235424 | Non-invasive prediction of blood glucose trends during hypoglycemia |
| Q64359428 | Nontargeted Pattern Recognition in the Search for Pyrolysis Gas Chromatography/Mass Spectrometry Resin Markers in Historic Lacquered Objects |
| Q87935335 | Novel approach for Newborn Errors in Metabolism Screening (NEMS) by NMR: clinical NEMS-by-NMR study in Turkey |
| Q36282865 | Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR. |
| Q104497951 | Nuclear Magnetic Resonance (NMR) Spectroscopy in Food Science: A Comprehensive Review |
| Q39108113 | Nuclear Magnetic Resonance Strategies for Metabolic Analysis |
| Q88588964 | Nuclear magnetic resonance (NMR)-based metabolomics for cancer research |
| Q38834940 | Nuclear magnetic resonance metabolomics and human liver diseases: The principles and evidence associated with protein and carbohydrate metabolism. |
| Q47110549 | Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer |
| Q38550509 | Nuclear magnetic resonance: a key metabolomics platform in the drug discovery process. |
| Q50667508 | Oblique rotation of factors: a novel pattern recognition strategy to classify fluorescence excitation-emission matrices of human blood plasma for early diagnosis of colorectal cancer. |
| Q98471067 | Omics Application in Animal Science-A Special Emphasis on Stress Response and Damaging Behaviour in Pigs |
| Q38813546 | Omics Profiling in Precision Oncology |
| Q114869566 | On Problems of the Comprehensive Chemical Profiling of Medicinal Plants |
| Q61817591 | Osteoarthritic Synovial Fluid Modulates Cell Phenotype and Metabolic Behavior |
| Q59210808 | Overoptimism in cross-validation when using partial least squares-discriminant analysis for omics data: a systematic study |
| Q114867891 | PROBLEMS OF COMPREHENSIVE CHEMICAL PROFILING OF MEDICINAL PLANTS |
| Q88293961 | PepsNMR for 1H NMR metabolomic data pre-processing |
| Q45951487 | Plant metabolism as studied by NMR spectroscopy. |
| Q38193578 | Potential input from metabolomics for exploring and understanding the links between environment and health. |
| Q30903618 | Preprocessing of NMR metabolomics data |
| Q87387000 | Profiling human blood serum metabolites by nuclear magnetic resonance spectroscopy: a comprehensive tool for the evaluation of hemodialysis efficiency |
| Q35154241 | Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children |
| Q118561679 | Prospects and challenges of cancer systems medicine: from genes to disease networks |
| Q30801268 | Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder |
| Q114870939 | Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder |
| Q47696312 | Qualitative and Quantitative NMR Approaches in Blood Serum Lipidomics |
| Q26766345 | Radiation Metabolomics: Current Status and Future Directions |
| Q57000241 | Rapid LC-MS-based metabolomics method to study theFusariuminfection of barley |
| Q30991740 | Recent developments in sample preparation and data pre-treatment in metabonomics research. |
| Q28076129 | Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis |
| Q50321973 | Recommended strategies for spectral processing and post-processing of 1D 1H-NMR data of biofluids with a particular focus on urine. |
| Q47565977 | Reconstruction of HMBC Correlation Networks: A Novel NMR-Based Contribution to Metabolite Mixture Analysis |
| Q38558628 | Review of validation and reporting of non-targeted fingerprinting approaches for food authentication |
| Q38828895 | Risk factors and biomarkers of age-related macular degeneration |
| Q30748761 | Sample preparation issues in NMR-based plant metabolomics: optimisation for Vitis wood samples |
| Q102069622 | Sanitary Conditions Affect the Colonic Microbiome and the Colonic and Systemic Metabolome of Female Pigs |
| Q31030042 | Simple and Effective Way for Data Preprocessing Selection Based on Design of Experiments |
| Q57703568 | Simultaneous acquisition of three NMR spectra in a single experiment for rapid resonance assignments in metabolomics |
| Q36999654 | Simultaneous, untargeted metabolic profiling of polar and nonpolar metabolites by LC-Q-TOF mass spectrometry |
| Q111032911 | Soil phosphorus forms show only minor changes across a 5000-year-old boreal wildfire chronosequence |
| Q93007191 | Special Issue on "NMR-Based Metabolomics and Its Applications Volume 2" |
| Q59613034 | Spectral Representation of Proton NMR Spectroscopy for the Pattern Recognition of Complex Materials |
| Q92133202 | Stable isotope labeling combined with liquid chromatography-tandem mass spectrometry for comprehensive analysis of short-chain fatty acids |
| Q59160030 | Strategies for Data Handling and Statistical Analysis in Metabolomics Studies |
| Q30986675 | Strategy for NMR metabolomic analysis of urine in mouse models of obesity--from sample collection to interpretation of acquired data |
| Q52953465 | Targeted metabolic profiling of wounds in diabetic and nondiabetic mice. |
| Q37032666 | Techniques and Approaches to Genetic Analyses in Nephrological Disorders |
| Q57025692 | The General Explanation Method with NMR Spectroscopy Enables the Identification of Metabolite Profiles Specific for Normal and Tumor Cell Lines |
| Q46248728 | The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges. |
| Q38678440 | The analytical process to search for metabolomics biomarkers |
| Q114868783 | The exposome paradigm to predict environmental health in terms of systemic homeostasis and resource balance based on NMR data science |
| Q28077113 | The non-canonical functions of the heme oxygenases |
| Q38936269 | Tissue-Based Metabolomics to Analyze the Breast Cancer Metabolome. |
| Q114870323 | Toxicometabolomics: Small Molecules to Answer Big Toxicological Questions |
| Q26998663 | Translational metabolomics in cancer research |
| Q64069274 | Ultra-Clean Pure Shift H-NMR applied to metabolomics profiling |
| Q38211764 | Uncovering the molecular networks in periodontitis |
| Q34318248 | Unraveling biochemical pathways affected by mitochondrial dysfunctions using metabolomic approaches |
| Q33358382 | Unravelling of the health effects of polyphenols is a complex puzzle complicated by metabolism |
| Q61963875 | Untargeted metabolic profiling of saliva by liquid chromatography-mass spectrometry for the identification of potential diagnostic biomarkers of asthma |
| Q42293369 | Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma |
| Q37411905 | Volume determination with two standards allows absolute quantification and improved chemometric analysis of metabolites by NMR from submicroliter samples. |
| Q54978466 | speaq 2.0: A complete workflow for high-throughput 1D NMR spectra processing and quantification. |
| Q57523683 | speaq 2.0: a complete workflow for high-throughput 1D NMR spectra processing and quantification |
Search more.